Smallpox-Related, Monkeypox -- Worldwide/Unknown
Bavarian Nordic announced that the FDA has approved Jynneos, a live, nonreplicating vaccine for the prevention of smallpox and monkeypox disease in adults aged 18 years or older who are at a high risk for smallpox or monkeypox infection. The new vaccine from Bavarian Nordic marks the only FDA-approved vaccine for the prevention of monkeypox.
"The licensure of this vaccine not only enhances domestic biodefense and global health security but also demonstrates what can be accomplished for the
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?6699452&promed&0
No comments:
Post a Comment